View ValuationScientific Industries 将来の成長Future 基準チェック /06現在、 Scientific Industriesの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Medical Equipment 収益成長16.4%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • Dec 30Scientific Industries, Inc., Annual General Meeting, Jan 22, 2026Scientific Industries, Inc., Annual General Meeting, Jan 22, 2026. Location: x0aavfc8zqiyaj0hihrame1, meeting id: 852 9343 8455, United Statesお知らせ • Nov 20Scientific Industries, Inc. to Report Q3, 2025 Results on Nov 19, 2025Scientific Industries, Inc. announced that they will report Q3, 2025 results at 4:00 PM, US Eastern Standard Time on Nov 19, 2025お知らせ • Nov 15Scientific Industries, Inc. announced delayed 10-Q filingOn 11/14/2025, Scientific Industries, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Aug 19Scientific Industries, Inc. to Report Q2, 2025 Results on Aug 19, 2025Scientific Industries, Inc. announced that they will report Q2, 2025 results at 4:00 PM, US Eastern Standard Time on Aug 19, 2025お知らせ • Aug 15Scientific Industries, Inc. announced delayed 10-Q filingOn 08/14/2025, Scientific Industries, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • May 13Scientific Industries, Inc. to Report Q3, 2025 Results on May 13, 2025Scientific Industries, Inc. announced that they will report Q3, 2025 results After-Market on May 13, 2025お知らせ • Nov 13Scientific Industries, Inc. to Report Q3, 2024 Results on Nov 15, 2024Scientific Industries, Inc. announced that they will report Q3, 2024 results Pre-Market on Nov 15, 2024お知らせ • Aug 15Scientific Industries, Inc. to Report Q2, 2024 Results on Aug 15, 2024Scientific Industries, Inc. announced that they will report Q2, 2024 results at 9:30 AM, US Eastern Standard Time on Aug 15, 2024お知らせ • May 12Scientific Industries, Inc. to Report Q1, 2024 Results on May 16, 2024Scientific Industries, Inc. announced that they will report Q1, 2024 results at 9:30 AM, US Eastern Standard Time on May 16, 2024お知らせ • Apr 17Scientific Industries, Inc. Announces Appointment of Michael Blechman to the Board of DirectorsScientific Industries, Inc. announced the appointment of Michael Blechman to the Board of Directors of SI effective April 12, 2024. Mr. Blechman filled a Board vacancy and replaces Mr. Marcus Frampton, who recently resigned, as a Class B director. Michael Blechman brings over three decades of experience in sales, marketing, operations and strategic planning. As CEO of Automated Control Concepts, Inc. ("ACC") he led the organization through 20 years of profitable operations and positive shareholder returns, culminating in a successful transaction with a private equity investor. While at ACC, Michael spearheaded their entry into the biotech product space with the introduction of the highly effective Lab Owl bioreactor control and information system.お知らせ • Apr 16Scientific Industries, Inc., Annual General Meeting, May 17, 2024Scientific Industries, Inc., Annual General Meeting, May 17, 2024, at 11:00 US Eastern Standard Time. Agenda: To elect two class c directors to the company's board of directors to serve until the company’s annual meeting of stockholders with respect to the year ending December 31, 2026 and until the election and qualification of their respective successors; to ratify the appointment of MAZARS USA LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2024; and to transact such other business as may properly come before the annual meeting and any adjournments or postponements thereof.お知らせ • Mar 08Scientific Industries and Scientific Bioprocessing Inc. Announce Board ChangesScientific Industries, Inc. announced the appointment of John Nicols to the Board of Directors of SI and Chairman of its wholly, owned subsidiary, Scientific Bioprocessing Inc., effective March 4, 2024. Mr. Nicols replaces Mr. John A. Moore as Chairman of SBI. Mr. John Nicols brings over three decades of experience in delivering sustained growth and value creation across diverse global businesses, from cutting-edge biotechnologies to traditional chemistry. He is the former president and CEO of Codexis, where he led the growth and transformation of Codexis into a leading synthetic biology company. From 2013 to 2022, Nicols grew Codexis' product sales nine-fold to exceed $100 million, commercializing dozens of new products across pharmaceutical, food and nutrition, and life science tools verticals. Prior to Codexis, Nicols held various executive roles spanning his 22 years at Albemarle Corp, where he grew their largest business unit to more than $1 billion in global sales. Nicols received a M.B.A. from the Massachusetts Institute of Technology and a B.S. degree in chemical engineering from the Polytechnic Institute of New York University. Mr. Nicols is a NACD Director Certified Board partner, and he currently serves as Chair of both Antheia, a synthetic biology-based producer for the pharmaceutical industry, and Solve M.E., a leading not-for-profit seeking cures for debilitating infection associated chronic diseases like ME/CFS and Long Covid.お知らせ • Nov 14Scientific Industries, Inc. to Report Q3, 2023 Results on Nov 14, 2023Scientific Industries, Inc. announced that they will report Q3, 2023 results After-Market on Nov 14, 2023お知らせ • Aug 12Scientific Industries, Inc. to Report Q2, 2023 Results on Aug 14, 2023Scientific Industries, Inc. announced that they will report Q2, 2023 results at 4:00 PM, US Eastern Standard Time on Aug 14, 2023お知らせ • Jun 15Scientific Industries Announces Retirement of Joseph G. Cremonese as Member of Board of DirectorsScientific Industries, Inc. announced that Joseph G. Cremonese, a member of the Company's board of directors is retiring and has therefore, resigned, from the Company's Board of Directors, effective June 13, 2023.お知らせ • May 12Scientific Industries, Inc. to Report Q1, 2023 Results on May 16, 2023Scientific Industries, Inc. announced that they will report Q1, 2023 results at 9:30 AM, US Eastern Standard Time on May 16, 2023お知らせ • Dec 21Scientific Industries, Inc., Annual General Meeting, Jan 27, 2023Scientific Industries, Inc., Annual General Meeting, Jan 27, 2023, at 11:00 US Eastern Standard Time. Agenda: To elect two class B directors to the company's board of directors to serve until the company’s annual meeting of stockholders with respect to the year ending December 31, 2025 and until the election and qualification of their respective successors; to ratify the appointment of Macias Gini and O’Connell LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2022; and to discuss other matters.お知らせ • Nov 30Scientific Industries Launches New VIVID(R) LITE Automated Pill CounterScientific Industries, Inc. announced the launch of a new automated pill counter product - VIVID LITE. The new VIVID LITE is built on a Company-patented counting algorithm that utilizes photo optical object recognition technology to count pills for pharmacies, pharmaceutical manufacturing, and packaging applications. Additional features and benefits of VIVID LITE include the ability to count virtually every type of available pill including translucent pills, assistance with identification of incorrect pills, large counting tray and dispensing tubes, and Wifi/Ethernet/USB capabilities in a space-saving model. The VIVID LITE provides superior counting accuracy, and will be produced in the Company's Bohemia, NYU.S. manufacturing facility. The Company has also re-launched a rebranded version of its original VIVID pill counter as the VIVID ONE. The VIVID ONE has been upgraded with a super-fast counting engine, ability to integrate with most popular pharmacy management systems, ability to count virtually every type of pill, and also incorporates the Company's proprietary VIVID PLUS cloud-based software, which will be free to the customer for the first year, and then available at an annual subscription. Among many of the benefits of VIVID PLUS are access to the Medispan® drug database, free automatic software updates, reporting and analytics, and tracking and tracing under GS1 standards for the new regulatory requirements for improved patient safety.お知らせ • Nov 12Scientific Industries, Inc. to Report Q1, 2023 Results on Nov 15, 2022Scientific Industries, Inc. announced that they will report Q1, 2023 results at 9:30 AM, US Eastern Standard Time on Nov 15, 2022お知らせ • Sep 29Scientific Industries, Inc. to Report Q4, 2022 Results on Sep 29, 2022Scientific Industries, Inc. announced that they will report Q4, 2022 results at 9:30 AM, US Eastern Standard Time on Sep 29, 2022お知らせ • Apr 14Scientific Industries, Inc Announces Executive ChangesEffective April 11, 2022, Scientific Industries, Inc. hired Reginald Averilla as its Chief Financial Officer, replacing Helena R. Santos in that role, which she had held since August 2002. Mr. Averilla brings to the Company over 10 years of financial accounting and management experience, including private and public company governance and mergers and acquisitions. From July 2020 to April 2022, Mr. Averilla served as VP Controller of Medical Knowledge Group, a privately held company that provides marketing solutions in the biopharmaceutical industry. From 2017 to July 2020, Mr. Averilla served as VP Controller for Film Expo Group, a privately held company that organizes events in the motion picture industry.お知らせ • Apr 06Scientific Industries, Inc. Announces Executive ChangesEffective April 1, 2022, by mutual agreement between the Scientific Industries, Inc., (Company) Mr. Reinhard Vogt and his affiliate Societt Reinhard and Noah Vogt AG o GmbH, the consulting agreement among them dated July 20, 2020, as amended, was terminated and, the ninety (90) day notice period required under the agreement was waived and the Company made a single payment to Mr. Vogt of the consulting fees that would otherwise have been payable by the Company during such notice period. In connection with such termination, Mr. Vogt resigned from his positions as a Class A Director of the Company's Board of Directors.お知らせ • Mar 04Scientific Industries, Inc. announced that it has received $3.022008 million in fundingScientific Industries, Inc. announced that it has entered into securities purchase agreement for the issuance of 549,456 common shares at issue price of $5.50 per share for gross proceeds of $3,022,008 on March 2, 2022. The company also issued warrants to purchase 274,727 common shares of the company at an exercise price of $5.50 per share for a period of 5 years from the closing of the transaction.お知らせ • Feb 15Scientific Industries, Inc. announced delayed 10-Q filingOn 02/14/2022, Scientific Industries, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Sep 29Scientific Industries, Inc. announced delayed annual 10-K filingOn 09/27/2021, Scientific Industries, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Feb 13Scientific Industries, Inc. announced delayed 10-Q filingOn 02/12/2021, Scientific Industries, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Jan 23Scientific Industries, Inc., Annual General Meeting, Feb 26, 2021Scientific Industries, Inc., Annual General Meeting, Feb 26, 2021, at 11:00 US Eastern Standard Time. Agenda: To elect two Class C Directors to the Company's Board of Directors to serve until the Companys annual meeting of stockholders with respect to the year ending June 30, 2023 and until the election and qualification of their respective successors; to consider and act upon a proposal to approve an amendment to the Certificate of Incorporation of the Company; to consider and act upon a proposal to approve an amendment to the 2012 Stock Option Plan of the Company; to ratify the appointment of Nussbaum Berg Klein & Wolpow, CPAs LLP as the Companys independent registered public accounting firm for the fiscal year ending June 30, 2021; and to transact such other business.お知らせ • Jan 09Scientific Industries, Inc. Announces Resignation of Mr. John F.F. Watkins as A Class C DirectorScientific Industries, Inc. announced that On January 8, 2021, the Board accepted the resignation of Mr. John F.F. Watkins as a Class C Director. Mr. Watkins resignation was not the result of any dispute or disagreement with the Company. The Company will pay Mr. Watkins director fees through December 31, 2020.お知らせ • Nov 13Scientific Industries, Inc. announced delayed 10-Q filingOn 11/12/2020, Scientific Industries, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Sep 29Scientific Industries, Inc. announced delayed annual 10-K filingOn 09/28/2020, Scientific Industries, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Scientific Industries は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測OTCPK:SCND - アナリストの将来予測と過去の財務データ ( )USD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数3/31/20265-7-5-5N/A12/31/20255-7-6-5N/A9/30/202511-1-4-4N/A6/30/202511-6-4-4N/A3/31/20253-8-4-4N/A12/31/20245-8-4-4N/A9/30/20246-8-5-5N/A6/30/20248-8-5-5N/A3/31/202411-9-6-6N/A12/31/202311-9-6-6N/A9/30/202311-9-6-6N/A6/30/202311-9-7-7N/A3/31/202311-16-7-6N/A12/31/202211-16-7-6N/A9/30/202211-6-7-6N/A6/30/202211-14-6-5N/A3/31/202211-5-5-4N/A12/31/202111-5-5-4N/A9/30/202111-4-4-4N/A6/30/202110-3-4-4N/A3/31/20219-2-2-2N/A12/31/20208-1-1-1N/A9/30/20208-100N/A6/30/20208000N/A3/31/20209000N/A12/31/2019101N/A0N/A9/30/2019100N/A0N/A6/30/2019101N/A1N/A3/31/2019101N/A1N/A12/31/2018100N/A1N/A9/30/201890N/A1N/A6/30/201880N/A0N/A3/31/201870N/A0N/A12/31/201770N/A0N/A9/30/201780N/A0N/A6/30/201780N/A0N/A3/31/2017110N/A1N/A12/31/2016100N/A1N/A9/30/2016100N/A1N/A6/30/2016100N/A1N/A3/31/201680N/A0N/A12/31/201580N/A0N/A9/30/201580N/A0N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: SCNDの予測収益成長が 貯蓄率 ( 3.5% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: SCNDの収益がUS市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: SCNDの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: SCNDの収益がUS市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: SCNDの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: SCNDの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YHealthcare 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/03 00:42終値2026/06/26 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Scientific Industries, Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Paul KnightKeyBanc Capital Markets Inc.
お知らせ • Dec 30Scientific Industries, Inc., Annual General Meeting, Jan 22, 2026Scientific Industries, Inc., Annual General Meeting, Jan 22, 2026. Location: x0aavfc8zqiyaj0hihrame1, meeting id: 852 9343 8455, United States
お知らせ • Nov 20Scientific Industries, Inc. to Report Q3, 2025 Results on Nov 19, 2025Scientific Industries, Inc. announced that they will report Q3, 2025 results at 4:00 PM, US Eastern Standard Time on Nov 19, 2025
お知らせ • Nov 15Scientific Industries, Inc. announced delayed 10-Q filingOn 11/14/2025, Scientific Industries, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Aug 19Scientific Industries, Inc. to Report Q2, 2025 Results on Aug 19, 2025Scientific Industries, Inc. announced that they will report Q2, 2025 results at 4:00 PM, US Eastern Standard Time on Aug 19, 2025
お知らせ • Aug 15Scientific Industries, Inc. announced delayed 10-Q filingOn 08/14/2025, Scientific Industries, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • May 13Scientific Industries, Inc. to Report Q3, 2025 Results on May 13, 2025Scientific Industries, Inc. announced that they will report Q3, 2025 results After-Market on May 13, 2025
お知らせ • Nov 13Scientific Industries, Inc. to Report Q3, 2024 Results on Nov 15, 2024Scientific Industries, Inc. announced that they will report Q3, 2024 results Pre-Market on Nov 15, 2024
お知らせ • Aug 15Scientific Industries, Inc. to Report Q2, 2024 Results on Aug 15, 2024Scientific Industries, Inc. announced that they will report Q2, 2024 results at 9:30 AM, US Eastern Standard Time on Aug 15, 2024
お知らせ • May 12Scientific Industries, Inc. to Report Q1, 2024 Results on May 16, 2024Scientific Industries, Inc. announced that they will report Q1, 2024 results at 9:30 AM, US Eastern Standard Time on May 16, 2024
お知らせ • Apr 17Scientific Industries, Inc. Announces Appointment of Michael Blechman to the Board of DirectorsScientific Industries, Inc. announced the appointment of Michael Blechman to the Board of Directors of SI effective April 12, 2024. Mr. Blechman filled a Board vacancy and replaces Mr. Marcus Frampton, who recently resigned, as a Class B director. Michael Blechman brings over three decades of experience in sales, marketing, operations and strategic planning. As CEO of Automated Control Concepts, Inc. ("ACC") he led the organization through 20 years of profitable operations and positive shareholder returns, culminating in a successful transaction with a private equity investor. While at ACC, Michael spearheaded their entry into the biotech product space with the introduction of the highly effective Lab Owl bioreactor control and information system.
お知らせ • Apr 16Scientific Industries, Inc., Annual General Meeting, May 17, 2024Scientific Industries, Inc., Annual General Meeting, May 17, 2024, at 11:00 US Eastern Standard Time. Agenda: To elect two class c directors to the company's board of directors to serve until the company’s annual meeting of stockholders with respect to the year ending December 31, 2026 and until the election and qualification of their respective successors; to ratify the appointment of MAZARS USA LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2024; and to transact such other business as may properly come before the annual meeting and any adjournments or postponements thereof.
お知らせ • Mar 08Scientific Industries and Scientific Bioprocessing Inc. Announce Board ChangesScientific Industries, Inc. announced the appointment of John Nicols to the Board of Directors of SI and Chairman of its wholly, owned subsidiary, Scientific Bioprocessing Inc., effective March 4, 2024. Mr. Nicols replaces Mr. John A. Moore as Chairman of SBI. Mr. John Nicols brings over three decades of experience in delivering sustained growth and value creation across diverse global businesses, from cutting-edge biotechnologies to traditional chemistry. He is the former president and CEO of Codexis, where he led the growth and transformation of Codexis into a leading synthetic biology company. From 2013 to 2022, Nicols grew Codexis' product sales nine-fold to exceed $100 million, commercializing dozens of new products across pharmaceutical, food and nutrition, and life science tools verticals. Prior to Codexis, Nicols held various executive roles spanning his 22 years at Albemarle Corp, where he grew their largest business unit to more than $1 billion in global sales. Nicols received a M.B.A. from the Massachusetts Institute of Technology and a B.S. degree in chemical engineering from the Polytechnic Institute of New York University. Mr. Nicols is a NACD Director Certified Board partner, and he currently serves as Chair of both Antheia, a synthetic biology-based producer for the pharmaceutical industry, and Solve M.E., a leading not-for-profit seeking cures for debilitating infection associated chronic diseases like ME/CFS and Long Covid.
お知らせ • Nov 14Scientific Industries, Inc. to Report Q3, 2023 Results on Nov 14, 2023Scientific Industries, Inc. announced that they will report Q3, 2023 results After-Market on Nov 14, 2023
お知らせ • Aug 12Scientific Industries, Inc. to Report Q2, 2023 Results on Aug 14, 2023Scientific Industries, Inc. announced that they will report Q2, 2023 results at 4:00 PM, US Eastern Standard Time on Aug 14, 2023
お知らせ • Jun 15Scientific Industries Announces Retirement of Joseph G. Cremonese as Member of Board of DirectorsScientific Industries, Inc. announced that Joseph G. Cremonese, a member of the Company's board of directors is retiring and has therefore, resigned, from the Company's Board of Directors, effective June 13, 2023.
お知らせ • May 12Scientific Industries, Inc. to Report Q1, 2023 Results on May 16, 2023Scientific Industries, Inc. announced that they will report Q1, 2023 results at 9:30 AM, US Eastern Standard Time on May 16, 2023
お知らせ • Dec 21Scientific Industries, Inc., Annual General Meeting, Jan 27, 2023Scientific Industries, Inc., Annual General Meeting, Jan 27, 2023, at 11:00 US Eastern Standard Time. Agenda: To elect two class B directors to the company's board of directors to serve until the company’s annual meeting of stockholders with respect to the year ending December 31, 2025 and until the election and qualification of their respective successors; to ratify the appointment of Macias Gini and O’Connell LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2022; and to discuss other matters.
お知らせ • Nov 30Scientific Industries Launches New VIVID(R) LITE Automated Pill CounterScientific Industries, Inc. announced the launch of a new automated pill counter product - VIVID LITE. The new VIVID LITE is built on a Company-patented counting algorithm that utilizes photo optical object recognition technology to count pills for pharmacies, pharmaceutical manufacturing, and packaging applications. Additional features and benefits of VIVID LITE include the ability to count virtually every type of available pill including translucent pills, assistance with identification of incorrect pills, large counting tray and dispensing tubes, and Wifi/Ethernet/USB capabilities in a space-saving model. The VIVID LITE provides superior counting accuracy, and will be produced in the Company's Bohemia, NYU.S. manufacturing facility. The Company has also re-launched a rebranded version of its original VIVID pill counter as the VIVID ONE. The VIVID ONE has been upgraded with a super-fast counting engine, ability to integrate with most popular pharmacy management systems, ability to count virtually every type of pill, and also incorporates the Company's proprietary VIVID PLUS cloud-based software, which will be free to the customer for the first year, and then available at an annual subscription. Among many of the benefits of VIVID PLUS are access to the Medispan® drug database, free automatic software updates, reporting and analytics, and tracking and tracing under GS1 standards for the new regulatory requirements for improved patient safety.
お知らせ • Nov 12Scientific Industries, Inc. to Report Q1, 2023 Results on Nov 15, 2022Scientific Industries, Inc. announced that they will report Q1, 2023 results at 9:30 AM, US Eastern Standard Time on Nov 15, 2022
お知らせ • Sep 29Scientific Industries, Inc. to Report Q4, 2022 Results on Sep 29, 2022Scientific Industries, Inc. announced that they will report Q4, 2022 results at 9:30 AM, US Eastern Standard Time on Sep 29, 2022
お知らせ • Apr 14Scientific Industries, Inc Announces Executive ChangesEffective April 11, 2022, Scientific Industries, Inc. hired Reginald Averilla as its Chief Financial Officer, replacing Helena R. Santos in that role, which she had held since August 2002. Mr. Averilla brings to the Company over 10 years of financial accounting and management experience, including private and public company governance and mergers and acquisitions. From July 2020 to April 2022, Mr. Averilla served as VP Controller of Medical Knowledge Group, a privately held company that provides marketing solutions in the biopharmaceutical industry. From 2017 to July 2020, Mr. Averilla served as VP Controller for Film Expo Group, a privately held company that organizes events in the motion picture industry.
お知らせ • Apr 06Scientific Industries, Inc. Announces Executive ChangesEffective April 1, 2022, by mutual agreement between the Scientific Industries, Inc., (Company) Mr. Reinhard Vogt and his affiliate Societt Reinhard and Noah Vogt AG o GmbH, the consulting agreement among them dated July 20, 2020, as amended, was terminated and, the ninety (90) day notice period required under the agreement was waived and the Company made a single payment to Mr. Vogt of the consulting fees that would otherwise have been payable by the Company during such notice period. In connection with such termination, Mr. Vogt resigned from his positions as a Class A Director of the Company's Board of Directors.
お知らせ • Mar 04Scientific Industries, Inc. announced that it has received $3.022008 million in fundingScientific Industries, Inc. announced that it has entered into securities purchase agreement for the issuance of 549,456 common shares at issue price of $5.50 per share for gross proceeds of $3,022,008 on March 2, 2022. The company also issued warrants to purchase 274,727 common shares of the company at an exercise price of $5.50 per share for a period of 5 years from the closing of the transaction.
お知らせ • Feb 15Scientific Industries, Inc. announced delayed 10-Q filingOn 02/14/2022, Scientific Industries, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Sep 29Scientific Industries, Inc. announced delayed annual 10-K filingOn 09/27/2021, Scientific Industries, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Feb 13Scientific Industries, Inc. announced delayed 10-Q filingOn 02/12/2021, Scientific Industries, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jan 23Scientific Industries, Inc., Annual General Meeting, Feb 26, 2021Scientific Industries, Inc., Annual General Meeting, Feb 26, 2021, at 11:00 US Eastern Standard Time. Agenda: To elect two Class C Directors to the Company's Board of Directors to serve until the Companys annual meeting of stockholders with respect to the year ending June 30, 2023 and until the election and qualification of their respective successors; to consider and act upon a proposal to approve an amendment to the Certificate of Incorporation of the Company; to consider and act upon a proposal to approve an amendment to the 2012 Stock Option Plan of the Company; to ratify the appointment of Nussbaum Berg Klein & Wolpow, CPAs LLP as the Companys independent registered public accounting firm for the fiscal year ending June 30, 2021; and to transact such other business.
お知らせ • Jan 09Scientific Industries, Inc. Announces Resignation of Mr. John F.F. Watkins as A Class C DirectorScientific Industries, Inc. announced that On January 8, 2021, the Board accepted the resignation of Mr. John F.F. Watkins as a Class C Director. Mr. Watkins resignation was not the result of any dispute or disagreement with the Company. The Company will pay Mr. Watkins director fees through December 31, 2020.
お知らせ • Nov 13Scientific Industries, Inc. announced delayed 10-Q filingOn 11/12/2020, Scientific Industries, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Sep 29Scientific Industries, Inc. announced delayed annual 10-K filingOn 09/28/2020, Scientific Industries, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.